The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125355252 12535525 2 F 201602 20160715 20160707 20160719 EXP US-ROCHE-1787740 ROCHE 48.50 YR F Y 48.58000 KG 20160719 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125355252 12535525 1 PS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Oral U 50722 500 MG BID
125355252 12535525 2 SS REMODULIN TREPROSTINIL 1 Intravenous drip 2.5 MG/ML Y 926618 0 .07 UG/KG
125355252 12535525 3 SS REMODULIN TREPROSTINIL 1 Intravenous drip Y 926618 0 .065 UG/KG
125355252 12535525 4 SS ADEMPAS RIOCIGUAT 1 Oral U 0 2.5 MG TID
125355252 12535525 5 C COLCRYS COLCHICINE 1 Oral 0 .6 MG QD
125355252 12535525 6 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral 1-2 TABLETS EVERY 6 HOURS AS NEEDED 0 TABLET
125355252 12535525 7 C VITAMIN B12 CYANOCOBALAMIN 1 Oral 0 500 UG TABLET TIW
125355252 12535525 8 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 0 40 MG QD
125355252 12535525 9 C LETAIRIS AMBRISENTAN 1 Oral 0 10 MG QD
125355252 12535525 10 C ZOLPIDEM TARTRATE. ZOLPIDEM TARTRATE 1 Oral 0 10 MG TABLET
125355252 12535525 11 C METOPROLOL TARTRATE. METOPROLOL TARTRATE 1 Oral 0 25 MG BID
125355252 12535525 12 C HYDROXYCHLOROQUINE SULPHATE HYDROXYCHLOROQUINE 1 Oral 0 200 MG BID
125355252 12535525 13 C LASIX FUROSEMIDE 1 Unknown 0 40 MG BID
125355252 12535525 14 C K-DUR POTASSIUM CHLORIDE 1 Unknown 0 BID
125355252 12535525 15 C SILVADENE SILVER SULFADIAZINE 1 Topical 1 APPLICATION TWICE DAILY AS NEEDED 0
125355252 12535525 16 C ASTELIN (UNITED STATES) 2 Unknown 0 137 UG
125355252 12535525 17 C ZANTAC RANITIDINE HYDROCHLORIDE 1 Oral ONCE AT BEDTIME 0 300 MG
125355252 12535525 18 C PREDNISONE. PREDNISONE 1 Unknown 0 20 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125355252 12535525 1 Product used for unknown indication
125355252 12535525 2 Pulmonary hypertension
125355252 12535525 4 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125355252 12535525 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125355252 12535525 Cardiac failure high output
125355252 12535525 Cataract
125355252 12535525 Chronic kidney disease
125355252 12535525 Diarrhoea
125355252 12535525 Dyspnoea
125355252 12535525 Fluid retention
125355252 12535525 Hypokalaemia
125355252 12535525 Iron deficiency anaemia
125355252 12535525 Malaise
125355252 12535525 Oedema peripheral
125355252 12535525 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125355252 12535525 1 20160512 0
125355252 12535525 2 20151006 0
125355252 12535525 3 20160225 0